GO:0006651 diacylglycerol biosynthetic process: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006651 describes the chemical reactions and pathways that produce diacylglycerol (DAG), a glyceride with two acyl groups and a third position that can be H or an alkyl group.
• DAG is a central lipid second messenger that activates protein kinase C (PKC) isoforms and is a key node in insulin signaling and hepatic lipid metabolism.
• The DAG biosynthetic process intersects with phosphatidic acid (PA) metabolism and phospholipase D (PLD) signaling, linking lipid synthesis to neurotransmission and cell activation.
• Dysregulated DAG synthesis contributes to insulin resistance, type 2 diabetes, and altered muscle insulin sensitivity, making it a target for metabolic disease research.
• DAG generation is also implicated in early developmental events such as sperm-induced egg activation, where lipid signaling cascades are triggered.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of DAG biosynthetic enzymes and their roles in health and disease.
Description
Diacylglycerol (DAG) is a glyceride in which two of the three hydroxyl positions of glycerol are esterified with acyl groups, while the remaining position can be either a hydrogen or an alkyl group. The Gene Ontology term GO:0006651, diacylglycerol biosynthetic process, encompasses the chemical reactions and pathways that result in the formation of DAG. This process is fundamental to lipid metabolism and cell signaling, as DAG serves both as a biosynthetic intermediate for complex lipids and as a potent second messenger that recruits and activates proteins containing C1 domains, most notably protein kinase C (PKC) isoforms. Researchers study DAG biosynthesis because it sits at the crossroads of energy homeostasis, membrane biogenesis, and signal transduction. In insulin-sensitive tissues, DAG accumulation has been linked to impaired insulin signaling through PKCε-mediated phosphorylation of the insulin receptor, contributing to lipid-induced insulin resistance. Hepatic DAG content is also a key determinant of hepatic insulin resistance and type 2 diabetes, as reviewed by Perry et al.. Beyond metabolic disease, DAG signaling participates in neurotransmission via phosphatidic acid (PA) metabolism and phospholipase D (PLD) pathways, and in developmental processes such as egg activation. Understanding the enzymes and regulatory mechanisms that control DAG biosynthesis is therefore essential for both basic cell biology and translational research.
diacylglycerol biosynthetic process At A Glance
| GO ID | GO:0006651 |
|---|---|
| GO term | diacylglycerol biosynthetic process |
| Ontology | biological_process |
| Synonym | diacylglycerol anabolism; diacylglycerol biosynthesis; diacylglycerol formation; diacylglycerol synthesis; diglyceride biosynthesis |
| Major function | Production of diacylglycerol (DAG), a lipid second messenger and biosynthetic intermediate |
| Key enzymes | Phosphatidic acid phosphatase (PAP), phospholipase D (PLD), diacylglycerol kinase (DGK) in reverse reactions, and other lipases |
| Pathway context | Glycerolipid metabolism; phosphatidic acid metabolism; phospholipase D signaling |
| Cellular location | Endoplasmic reticulum, plasma membrane, and other membrane compartments |
| Related processes | Insulin signaling, PKC activation, neurotransmission, egg activation |
What Is GO:0006651?
GO:0006651, diacylglycerol biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of diacylglycerol, a glyceride in which any two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group. In simpler terms, it covers all the enzymatic steps that build DAG from precursor molecules such as phosphatidic acid or other lipids, as well as the pathways that regenerate DAG through hydrolysis of phospholipids or other glycerides.
Why Is diacylglycerol biosynthetic process Important in Cell Biology?
The diacylglycerol biosynthetic process is critically important because DAG is both a building block for membrane lipids and a signaling lipid that controls diverse cellular responses. DAG produced through this process activates PKC isoforms, which regulate cell growth, differentiation, and metabolism. In metabolic tissues, excessive DAG synthesis and accumulation are strongly associated with insulin resistance and type 2 diabetes, as DAG activates PKCε that impairs insulin receptor signaling. In the nervous system, DAG generated via phosphatidic acid and phospholipase D pathways contributes to neurotransmission and synaptic signaling. Additionally, DAG production is an early event in egg activation, highlighting its role in developmental biology. Thus, understanding GO:0006651 provides mechanistic insight into normal physiology and multiple disease states.
• DAG is a second messenger that activates PKC isoforms, influencing cell proliferation, differentiation, and metabolism.
• Hepatic DAG accumulation is a key mediator of hepatic insulin resistance and type 2 diabetes.
• DAG synthesized via phosphatidic acid phosphatase and phospholipase D pathways modulates neurotransmission.
• Altered DAG biosynthesis contributes to lipid-induced insulin resistance in skeletal muscle and liver.
• DAG signaling is involved in early developmental events such as sperm-induced egg activation.
• The process intersects with calcium and Rap1 signaling, integrating lipid and ionic signals.
• DAG serves as a precursor for phosphatidylcholine and other phospholipids, affecting membrane composition.
• Enzymes of DAG biosynthesis are potential therapeutic targets for metabolic disorders.
• Studying DAG biosynthesis helps explain how cells balance energy storage and signaling.
• CRISPR screens can identify novel regulators of DAG production and its downstream effects.
What Happens During diacylglycerol biosynthetic process?
Phosphatidic acid dephosphorylation
In simple terms: A phosphate group is removed from phosphatidic acid to create diacylglycerol.
The most direct route to DAG is the dephosphorylation of phosphatidic acid (PA) by phosphatidic acid phosphatases (PAPs), also known as lipins. This reaction converts PA into DAG and inorganic phosphate. This step is a major source of DAG for both lipid synthesis and signaling. The activity of PAP enzymes is regulated by phosphorylation and cellular localization, linking DAG production to growth factor and insulin signaling.
Phospholipase D-mediated PA generation and subsequent DAG formation
In simple terms: Phospholipase D makes phosphatidic acid, which is then converted to diacylglycerol.
Phospholipase D (PLD) hydrolyzes phosphatidylcholine to produce phosphatidic acid (PA) and choline. The PA generated by PLD can be subsequently dephosphorylated by PAP to yield DAG. This pathway is particularly important in cell signaling, as PLD is activated by various receptors and contributes to sustained DAG production for PKC activation. PLD-derived PA also has its own signaling functions, but its conversion to DAG is a key step in the biosynthetic process.
De novo synthesis from glycerol-3-phosphate
In simple terms: The cell builds diacylglycerol from scratch using glycerol-3-phosphate and fatty acids.
DAG can be synthesized de novo through the glycerol-3-phosphate pathway. Glycerol-3-phosphate is acylated to lysophosphatidic acid, then to phosphatidic acid, which is then dephosphorylated to DAG. This pathway is essential for the production of triacylglycerols and phospholipids. The enzymes involved include glycerol-3-phosphate acyltransferases (GPATs), acylglycerol-3-phosphate acyltransferases (AGPATs), and PAPs. This de novo route is a major contributor to hepatic DAG content and is linked to insulin resistance.
Hydrolysis of triacylglycerols and other glycerides
In simple terms: Diacylglycerol can also be made by breaking down triglycerides or other lipids.
DAG is generated by the hydrolysis of triacylglycerols (TAGs) by lipases such as adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). This reaction removes one acyl chain from TAG, producing DAG and a free fatty acid. This route is important for mobilizing stored fat and for generating DAG as a signaling molecule in response to hormonal cues. Additionally, the hydrolysis of phosphatidylinositol bisphosphate (PIP2) by phospholipase C (PLC) produces DAG and inositol trisphosphate (IP3), a classic signaling event.
Regulation by lipid kinases and phosphatases
In simple terms: Enzymes that add or remove phosphate groups control how much diacylglycerol is made.
The levels of DAG are tightly regulated by the opposing actions of lipid kinases and phosphatases. Diacylglycerol kinases (DGKs) phosphorylate DAG to phosphatidic acid, thereby terminating DAG signaling and recycling it into the PA pool. Conversely, PAPs dephosphorylate PA to DAG. This balance is critical for maintaining appropriate DAG levels for signaling and biosynthesis. DGK isoforms are regulated by calcium, diacylglycerol, and phosphorylation, integrating DAG metabolism with calcium signaling.
Key Genes Involved in GO:0006651 diacylglycerol biosynthetic process
The following genes and proteins are key players in the diacylglycerol biosynthetic process, based on their established roles in lipid metabolism and signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LPIN1 | Phosphatidic acid phosphatase; converts PA to DAG | Central to DAG synthesis; linked to insulin sensitivity and lipid metabolism |
| LPIN2 | Phosphatidic acid phosphatase; converts PA to DAG | Isoform-specific functions in metabolic tissues |
| LPIN3 | Phosphatidic acid phosphatase; converts PA to DAG | Potential role in hepatic DAG production |
| PLD1 | Phospholipase D; generates PA from phosphatidylcholine | Produces substrate for DAG synthesis; involved in signaling |
| PLD2 | Phospholipase D; generates PA from phosphatidylcholine | Regulates DAG production in response to receptor activation |
| DGKA | Diacylglycerol kinase; phosphorylates DAG to PA | Terminates DAG signaling; regulates PKC activation |
| DGKB | Diacylglycerol kinase; phosphorylates DAG to PA | Neuronal-specific functions in DAG metabolism |
| DGKG | Diacylglycerol kinase; phosphorylates DAG to PA | Modulates DAG levels in specific tissues |
| GPAT1 | Glycerol-3-phosphate acyltransferase; first step in de novo DAG synthesis | Contributes to hepatic DAG and TAG synthesis |
| GPAT2 | Glycerol-3-phosphate acyltransferase; first step in de novo DAG synthesis | Isoform with distinct substrate specificity |
| AGPAT1 | Acylglycerol-3-phosphate acyltransferase; second step in de novo synthesis | Produces PA for subsequent DAG formation |
| AGPAT2 | Acylglycerol-3-phosphate acyltransferase; second step in de novo synthesis | Mutations cause congenital generalized lipodystrophy |
| ATGL | Adipose triglyceride lipase; hydrolyzes TAG to DAG | Generates DAG from stored fat; key in lipolysis |
| HSL | Hormone-sensitive lipase; hydrolyzes TAG and DAG | Regulates DAG levels during lipolysis |
| PLCB1 | Phospholipase C beta 1; hydrolyzes PIP2 to DAG and IP3 | Classic signaling route for DAG production |
| PLCG1 | Phospholipase C gamma 1; hydrolyzes PIP2 to DAG and IP3 | Receptor tyrosine kinase-coupled DAG generation |
| PKCε | Protein kinase C epsilon; activated by DAG | Mediates lipid-induced insulin resistance via DAG |
| DGAT1 | Diacylglycerol acyltransferase; converts DAG to TAG | Consumes DAG for TAG synthesis; regulates DAG levels |
How Is diacylglycerol biosynthetic process Regulated?
The diacylglycerol biosynthetic process is regulated at multiple levels. Hormones such as insulin and growth factors activate phospholipase C (PLC) and phospholipase D (PLD), increasing DAG production. Calcium signaling modulates the activity of diacylglycerol kinases (DGKs), which phosphorylate DAG to phosphatidic acid, thus attenuating DAG levels. Phosphatidic acid phosphatases (lipins) are regulated by phosphorylation and nuclear-cytoplasmic shuttling, controlling the conversion of PA to DAG. In metabolic tissues, excess fatty acid supply promotes de novo DAG synthesis, contributing to insulin resistance through PKCε activation. Additionally, exercise training can improve muscle insulin sensitivity and alter lipid metabolism, potentially affecting DAG levels. The interplay between Rap1 and calcium signaling also influences DAG production and downstream effects.
diacylglycerol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LPIN1 | Insulin resistance, type 2 diabetes | Liver-specific knockout mouse; CRISPR KO in HepG2 cells |
| PKCε | Lipid-induced insulin resistance | Point mutation knock-in of PKCε in mice; overexpression in myotubes |
| PLD1 | Neurotransmission, immune signaling | Neuron-specific KO; CRISPR KO in neuroblastoma cells |
| DGKA | Cancer, metabolic disorders | Knockout in cancer cell lines; overexpression in adipocytes |
| ATGL | Lipid storage, insulin sensitivity | Adipose-specific KO; CRISPR KO in 3T3-L1 adipocytes |
Insulin resistance and type 2 diabetes
Dysregulated DAG biosynthesis is a major contributor to insulin resistance. In liver and skeletal muscle, accumulation of DAG activates PKCε, which phosphorylates the insulin receptor at T1150, impairing insulin signaling. This mechanism links lipid overload to type 2 diabetes. Studies in humans show that exercise training improves muscle insulin sensitivity, partly by modulating lipid intermediates including DAG. Thus, targeting DAG synthesis enzymes could offer therapeutic strategies for metabolic disease.
Neurological and neurotransmission disorders
DAG produced via phosphatidic acid and PLD pathways is essential for neurotransmission. Phosphatidic acid and DAG regulate synaptic vesicle trafficking and receptor function. PLD signaling, which generates PA for DAG synthesis, is implicated in immune and neuronal signaling. Alterations in DAG metabolism may contribute to neurological conditions, though specific disease links require further investigation.
Developmental and reproductive biology
DAG signaling is an early event in egg activation. Sperm-induced activation triggers lipid signaling cascades that include DAG production, which is necessary for the resumption of meiosis and embryonic development. This highlights the importance of DAG biosynthesis beyond metabolic tissues.
From diacylglycerol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does LPIN1 knockout reduce hepatic DAG and improve insulin sensitivity? | Liver-specific LPIN1 knockout mouse; CRISPR KO in primary hepatocytes |
| Does a point mutation in PKCε prevent DAG-induced insulin resistance? | PKCε T1150A knock-in mouse; CRISPR point mutation in C2C12 myotubes |
| Can overexpression of DGKA lower DAG levels and enhance insulin signaling? | Adenoviral DGKA overexpression in liver; CRISPRa in HepG2 cells |
| What is the role of PLD1 in neurotransmission? | Neuron-specific PLD1 knockout; CRISPR KO in primary neurons |
| Does ATGL knockdown alter DAG content and lipolysis? | Adipose-specific ATGL KO; CRISPR KO in 3T3-L1 adipocytes |
| Can a tagged knock-in of LPIN1 reveal its subcellular localization? | LPIN1-HA knock-in via CRISPR in HeLa cells |
How to Study the diacylglycerol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | DAG species and other lipids | Quantify DAG levels in tissues or cells |
| CRISPR knockout screens | Genes affecting DAG levels | Identify novel regulators of DAG biosynthesis |
| Phosphoproteomics | Phosphorylation of signaling proteins | Detect PKCε-mediated insulin receptor phosphorylation |
| Western blotting | Protein expression and phosphorylation | Validate DAG-PKC signaling changes |
| Fluorescent DAG sensors | Real-time DAG dynamics | Image DAG production at membranes |
| RNA-seq | Transcriptional changes | Assess expression of DAG biosynthetic enzymes |
| Co-immunoprecipitation | Protein-protein interactions | Study enzyme complexes in DAG synthesis |
| Enzyme activity assays | PAP, PLD, DGK activities | Measure enzymatic rates in vitro |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics allows quantification of DAG species and other lipids in cells and tissues. This method is essential for measuring changes in DAG biosynthesis and accumulation in response to genetic or pharmacological perturbations.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate DAG levels and downstream signaling. For example, screens targeting lipid metabolic enzymes can reveal novel regulators of DAG biosynthesis and insulin sensitivity.
Phosphoproteomics and signaling assays
Phosphoproteomics can detect phosphorylation events downstream of DAG, such as PKCε-mediated phosphorylation of the insulin receptor at T1150. Western blotting with phospho-specific antibodies is commonly used to assess DAG-PKC signaling.
Live-cell imaging and fluorescent DAG sensors
Genetically encoded DAG sensors (e.g., C1 domain-based probes) enable real-time visualization of DAG dynamics at membrane compartments. This approach helps dissect spatial and temporal aspects of DAG biosynthesis.
How CRISPR Can Be Used to Study GO:0006651 diacylglycerol biosynthetic process
Knockout
CRISPR knockout of genes involved in DAG biosynthesis, such as LPIN1, PLD1, or DGKA, allows researchers to assess their contribution to DAG production and downstream phenotypes. For example, LPIN1 knockout in liver cells can reduce DAG levels and improve insulin sensitivity.
Point Mutation
Point mutations can be introduced to mimic or prevent phosphorylation events. For instance, a T1150A mutation in the insulin receptor prevents PKCε-mediated phosphorylation, blocking DAG-induced insulin resistance. CRISPR point mutation in PKCε can similarly test its role in DAG signaling.
Knock-in
Knock-in of tagged versions of DAG biosynthetic enzymes (e.g., LPIN1-HA) enables localization and interaction studies. CRISPR knock-in can also introduce disease-associated mutations to model their effects on DAG metabolism.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of DAG-producing enzymes like DGKA or PLD1 to study their impact on DAG levels and signaling. Overexpression of DGKA may lower DAG and enhance insulin sensitivity.
How EDITGENE Supports diacylglycerol biosynthetic process Research
Researchers studying diacylglycerol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in DAG production, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for diacylglycerol biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PLCE1 Knockout HEK293 Cell Line | EDJ-KQ1279 | Human | 51196 | Details Get a Quote |
| MOGAT2 Knockout HEK293 Cell Line | EDJ-KQ2657 | Human | 80168 | Details Get a Quote |
| DGAT2 Knockout HEK293 Cell Line | EDJ-KQ2928 | Human | 84649 | Details Get a Quote |
| GPAM Knockout HEK293 Cell Line | EDJ-KQ3039 | Human | 57678 | Details Get a Quote |
| PNPLA2 Knockout HEK293 Cell Line | EDJ-KQ3484 | Human | 57104 | Details Get a Quote |
| MOGAT1 Knockout HEK293 Cell Line | EDJ-KQ7560 | Human | 116255 | Details Get a Quote |
| PLA2G15 Knockout HEK293 Cell Line | EDJ-KQ8113 | Human | 23659 | Details Get a Quote |
| DGAT2 Knockout A-549 Cell Line | EDJ-KQ24034 | Human | 84649 | Details Get a Quote |
| DGAT2 Knockout HCT 116 Cell Line | EDJ-KQ24035 | Human | 84649 | Details Get a Quote |
| DGAT2 Knockout HeLa Cell Line | EDJ-KQ24036 | Human | 84649 | Details Get a Quote |
| PLA2G15 Knockout A-549 Cell Line | EDJ-KQ33992 | Human | 23659 | Details Get a Quote |
| PLA2G15 Knockout HCT 116 Cell Line | EDJ-KQ33993 | Human | 23659 | Details Get a Quote |
| PLA2G15 Knockout HeLa Cell Line | EDJ-KQ33994 | Human | 23659 | Details Get a Quote |
| PLCE1 Knockout A-549 Cell Line | EDJ-KQ20668 | Human | 51196 | Details Get a Quote |
| PLCE1 Knockout HCT 116 Cell Line | EDJ-KQ20669 | Human | 51196 | Details Get a Quote |
Displaying Records 1 To 15 Of 29 Records
Frequently Asked Questions About diacylglycerol biosynthetic process
What is GO:0006651?
GO:0006651 is the Gene Ontology term for diacylglycerol biosynthetic process, describing the chemical reactions and pathways that produce diacylglycerol (DAG).
What is diacylglycerol biosynthetic process?
It is the set of metabolic pathways that synthesize DAG, a glyceride with two acyl groups, which serves as a signaling lipid and biosynthetic intermediate.
What genes are involved in diacylglycerol biosynthetic process?
Key genes include LPIN1, LPIN2, LPIN3, PLD1, PLD2, DGKA, DGKB, GPAT1, AGPAT1, ATGL, HSL, PLCB1, PLCG1, and PKCε.
How is diacylglycerol synthesized?
DAG is synthesized by dephosphorylation of phosphatidic acid by lipins, by phospholipase D-mediated PA production followed by dephosphorylation, by de novo glycerol-3-phosphate pathway, and by hydrolysis of triacylglycerols or PIP2.
Why is diacylglycerol important in insulin resistance?
DAG activates PKCε, which phosphorylates the insulin receptor at T1150, impairing insulin signaling and contributing to insulin resistance and type 2 diabetes.
What diseases are linked to diacylglycerol biosynthesis?
Dysregulated DAG synthesis is linked to insulin resistance, type 2 diabetes, and potentially neurological and developmental disorders.
How can CRISPR be used to study diacylglycerol biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression can precisely manipulate genes like LPIN1, PKCε, and DGKA to study their roles in DAG production and signaling.
What methods measure diacylglycerol levels?
Lipidomics with mass spectrometry, fluorescent DAG sensors, and enzyme activity assays are commonly used to measure DAG levels and dynamics.
What is the role of phospholipase D in DAG synthesis?
Phospholipase D generates phosphatidic acid, which can be dephosphorylated to DAG, linking PLD signaling to DAG production.
Is diacylglycerol involved in egg activation?
Yes, DAG signaling is an early event in sperm-induced egg activation, contributing to developmental processes.
Conclusion
The diacylglycerol biosynthetic process (GO:0006651) is a fundamental metabolic pathway that produces DAG, a lipid with dual roles in membrane synthesis and cell signaling. Its dysregulation is implicated in insulin resistance, type 2 diabetes, and other conditions, making it a critical area of research. Advances in CRISPR-based models and lipidomics are enabling precise dissection of the enzymes and regulatory mechanisms involved. EDITGENE provides comprehensive services to support these investigations, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Xu W et al.. 2024. Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptor(T1150) phosphorylation pathway.. Cell Rep 43(10):114746 PMID: 39302831
- 2. Strålfors P. 1997. Insulin second messengers.. Bioessays 19(4):327-35 PMID: 9136630
- 3. Perry RJ et al.. 2014. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.. Nature 510(7503):84-91 PMID: 24899308
- 4. Raben DM et al.. 2017. Phosphatidic acid and neurotransmission.. Adv Biol Regul 63:15-21 PMID: 27671966
- 5. Kosuru R et al.. 2020. Integration of Rap1 and Calcium Signaling.. Int J Mol Sci 21(5) PMID: 32120817
- 6. Pesta D et al.. 2025. Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals.. Sci Adv 11(1):eadr8849 PMID: 39742483
- 7. Billah MM. 1993. Phospholipase D and cell signaling.. Curr Opin Immunol 5(1):114-23 PMID: 8383981
- 8. Nuccitelli R. 1991. How do sperm activate eggs?. Curr Top Dev Biol 25:1-16 PMID: 1743052
